{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T10:34:58Z","timestamp":1790073298519,"version":"4.0.1"},"reference-count":40,"publisher":"Spandidos Publications","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.3892\/or.2015.4231","type":"journal-article","created":{"date-parts":[[2015,8,27]],"date-time":"2015-08-27T08:08:58Z","timestamp":1440662938000},"page":"2289-2295","source":"Crossref","is-referenced-by-count":10,"title":["Immunotherapy for Lewis lung carcinoma utilizing dendritic cells infected with CK19 gene recombinant adenoviral vectors"],"prefix":"10.3892","volume":"34","author":[{"given":"Q.F.","family":"SUN","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X.N.","family":"ZHAO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.L.","family":"PENG","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.T.","family":"HAO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.P.","family":"ZHAO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"JIANG","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"XUE","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.Z.","family":"GUO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.H.","family":"YUN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"CONG","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X.G.","family":"ZHAO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2015,8,27]]},"reference":[{"key":"key20180107212146_b1-or-34-05-2289","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1002\/ijc.25516","article-title":"Estimates of worldwide burden of cancer in 2008: GLoBoCAn 2008","volume":"127","author":"Ferlay","year":"2010","journal-title":"Int J Cancer"},{"key":"key20180107212146_b2-or-34-05-2289","first-page":"56","article-title":"Lung cancer: Diagnosis and management","volume":"75","author":"Collins","year":"2007","journal-title":"Am Fam Physician"},{"key":"key20180107212146_b3-or-34-05-2289","first-page":"1419","article-title":"A naturally occurring mutant human epidermal growth factor receptor as a target for peptide vaccine immunotherapy of tumors","volume":"57","author":"Moscatello","year":"1997","journal-title":"Cancer Res"},{"key":"key20180107212146_b4-or-34-05-2289","first-page":"4247","article-title":"Epidermal growth factor receptor VIII peptide vaccination is efficacious against established intracerebral tumors","volume":"9","author":"Heimberger","year":"2003","journal-title":"Clin Cancer Res"},{"key":"key20180107212146_b5-or-34-05-2289","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s00262-004-0576-y","article-title":"Cellular antitumor immune response to a branched lysine multiple antigenic peptide containing epitopes of a common tumor-specific antigen in a rat glioma model","volume":"54","author":"Ciesielski","year":"2005","journal-title":"Cancer Immunol Immunother"},{"key":"key20180107212146_b6-or-34-05-2289","first-page":"L536","article-title":"Regulation of cytokeratin expression in rat lung alveolar epithelial cells in vitro","volume":"269","author":"Paine","year":"1995","journal-title":"Am J Physiol"},{"key":"key20180107212146_b7-or-34-05-2289","first-page":"317","article-title":"The prognostic value of cytokeratin 19 expression in non-small cell lung cancer","volume":"75","author":"Kosacka","year":"2007","journal-title":"Pneumonol Alergol Pol"},{"key":"key20180107212146_b8-or-34-05-2289","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1084\/jem.188.2.277","article-title":"gp100\/pmel 17 is a murine tumor rejection antigen: Induction of 'self'-reactive, tumoricidal T cells using high-affinity, altered peptide ligand","volume":"188","author":"Overwijk","year":"1998","journal-title":"J Exp Med"},{"key":"key20180107212146_b9-or-34-05-2289","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/32588","article-title":"Dendritic cells and the control of immunity","volume":"392","author":"Banchereau","year":"1998","journal-title":"Nature"},{"key":"key20180107212146_b10-or-34-05-2289","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1002\/ijc.1503","article-title":"Active immunization against cancer with dendritic cells: The near future","volume":"94","author":"Steinman","year":"2001","journal-title":"Int J Cancer"},{"key":"key20180107212146_b11-or-34-05-2289","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1038\/nm0797-808","article-title":"Sensitivity and reproducibility in adenoviral infectious titer determination","volume":"3","author":"Nyberg-Hoffman","year":"1997","journal-title":"Nat Med"},{"key":"key20180107212146_b12-or-34-05-2289","doi-asserted-by":"crossref","first-page":"9617","DOI":"10.1128\/JVI.74.20.9617-9628.2000","article-title":"Recombinant adenovirus induces maturation of dendritic cells via an NF-kappaB-dependent pathway","volume":"74","author":"Morelli","year":"2000","journal-title":"J Virol"},{"key":"key20180107212146_b13-or-34-05-2289","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1126\/science.7513904","article-title":"Role of bone marrow-derived cells in presenting MHC class I-restricted tumor antigens","volume":"264","author":"Huang","year":"1994","journal-title":"Science"},{"key":"key20180107212146_b14-or-34-05-2289","doi-asserted-by":"crossref","first-page":"4558","DOI":"10.4049\/jimmunol.164.9.4558","article-title":"Secondary lymphoid tissue chemokine mediates T cell-dependent antitumor responses in vivo","volume":"164","author":"Sharma","year":"2000","journal-title":"J Immunol"},{"key":"key20180107212146_b15-or-34-05-2289","doi-asserted-by":"crossref","first-page":"9482","DOI":"10.1073\/pnas.95.16.9482","article-title":"Murine dendritic cells pulsed with whole tumor lysates mediate potent antitumor immune responses in vitro and in vivo","volume":"95","author":"Fields","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20180107212146_b16-or-34-05-2289","first-page":"6445","article-title":"Tumor cell lysate-pulsed human dendritic cells induce a T-cell response against pancreatic carcinoma cells: An in vitro model for the assessment of tumor vaccines","volume":"61","author":"Schnurr","year":"2001","journal-title":"Cancer Res"},{"key":"key20180107212146_b17-or-34-05-2289","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/j.1749-6632.1993.tb44005.x","article-title":"Active specific immunotherapy of melanoma with allogeneic cell lysates. Rationale, results, and possible mechanisms of action","volume":"690","author":"Mitchell","year":"1993","journal-title":"Ann NY Acad Sci"},{"key":"key20180107212146_b18-or-34-05-2289","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1089\/10430340050015419","article-title":"Gene-modified dendritic cells for use in tumor vaccines","volume":"11","author":"Kirk","year":"2000","journal-title":"Hum Gene Ther"},{"key":"key20180107212146_b19-or-34-05-2289","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1084\/jem.191.10.1699","article-title":"Comparative analysis of genetically modified dendritic cells and tumor cells as therapeutic cancer vaccines","volume":"191","author":"Klein","year":"2000","journal-title":"J Exp Med"},{"key":"key20180107212146_b20-or-34-05-2289","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1002\/pros.20942","article-title":"Vaccination with recombinant adenoviruses and dendritic cells expressing prostate-specific antigens is effective in eliciting CTL and suppresses tumor growth in the experimental prostate cancer","volume":"69","author":"Kim","year":"2009","journal-title":"Prostate"},{"key":"key20180107212146_b21-or-34-05-2289","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1084\/jem.186.8.1247","article-title":"Dendritic cells genetically modified with an adenovirus vector encoding the cDnA for a model antigen induce protective and therapeutic antitumor immunity","volume":"186","author":"Song","year":"1997","journal-title":"J Exp Med"},{"key":"key20180107212146_b22-or-34-05-2289","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1097\/00002371-200001000-00008","article-title":"Generation of T-cell immunity to a murine melanoma using MART-1-engineered dendritic cells","volume":"23","author":"Ribas","year":"2000","journal-title":"J Immunother"},{"key":"key20180107212146_b23-or-34-05-2289","doi-asserted-by":"crossref","first-page":"699","DOI":"10.4049\/jimmunol.163.2.699","article-title":"Induction of antitumor immunity with dendritic cells transduced with adenovirus vector-encoding endogenous tumor-associated antigens","volume":"163","author":"Kaplan","year":"1999","journal-title":"J Immunol"},{"key":"key20180107212146_b24-or-34-05-2289","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/S0264-410X(03)00569-3","article-title":"In vitro induction of carcinoembryonic antigen (CEA)-specific cytotoxic T lymphocytes by dendritic cells transduced with recombinant adenoviruses","volume":"22","author":"Cho","year":"2003","journal-title":"Vaccine"},{"key":"key20180107212146_b25-or-34-05-2289","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1111\/j.1365-2249.2008.03724.x","article-title":"A dendritic cell-based tumour vaccine for lung cancer: Full-length XAGE-1b protein-pulsed dendritic cells induce specific cytotoxic T lymphocytes in vitro","volume":"153","author":"Zhou","year":"2008","journal-title":"Clin Exp Immunol"},{"key":"key20180107212146_b26-or-34-05-2289","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.lungcan.2009.07.007","article-title":"Antitumor effects of murine bone marrow-derived dendritic cells infected with xenogeneic livin alpha recombinant adenoviral vectors against Lewis lung carcinoma","volume":"68","author":"Xie","year":"2010","journal-title":"Lung Cancer"},{"key":"key20180107212146_b27-or-34-05-2289","doi-asserted-by":"crossref","first-page":"10245","DOI":"10.1128\/JVI.73.12.10245-10253.1999","article-title":"Adenoviruses activate human dendritic cells without polarization toward a T-helper type 1-inducing subset","volume":"73","author":"Rea","year":"1999","journal-title":"J Virol"},{"key":"key20180107212146_b28-or-34-05-2289","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/sj.gt.3301077","article-title":"Efficient transduction of mature CD83+ dendritic cells using recombinant adenovirus suppressed T cell stimulatory capacity","volume":"7","author":"Jonuleit","year":"2000","journal-title":"Gene Ther"},{"key":"key20180107212146_b29-or-34-05-2289","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s00262-003-0379-6","article-title":"Optimization of dendritic cell maturation and gene transfer by recombinant adenovirus","volume":"52","author":"Miller","year":"2003","journal-title":"Cancer Immunol Immunother"},{"key":"key20180107212146_b30-or-34-05-2289","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1128\/JVI.69.4.2004-2015.1995","article-title":"Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses","volume":"69","author":"Yang","year":"1995","journal-title":"J Virol"},{"key":"key20180107212146_b31-or-34-05-2289","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1016\/j.archoralbio.2006.05.005","article-title":"Increased levels of CK19 mRnA in oral squamous cell carcinoma tissue detected by relative quantification with real-time polymerase chain reaction","volume":"51","author":"Zhong","year":"2006","journal-title":"Arch Oral Biol"},{"key":"key20180107212146_b32-or-34-05-2289","first-page":"209","article-title":"Importance of the cytokeratins in cancer diagnosis","volume":"135","author":"Galus","year":"2007","journal-title":"Pol Merk Lek"},{"key":"key20180107212146_b33-or-34-05-2289","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1200\/JCO.2008.18.0497","article-title":"Cytokeratin-19 mRnA-positive circulating tumor cells after adjuvant chemotherapy in patients with early breast cancer","volume":"27","author":"Xenidis","year":"2009","journal-title":"J Clin Oncol"},{"key":"key20180107212146_b34-or-34-05-2289","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0140-6736(00)03566-2","article-title":"Molecular quantification and mapping of lymph-node micrometastases in cervical cancer","volume":"357","author":"Van Trappen","year":"2001","journal-title":"Lancet"},{"key":"key20180107212146_b35-or-34-05-2289","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1002\/ijc.23451","article-title":"Intra-operative rapid diagnostic method based on CK19 mRnA expression for the detection of lymph node metastases in breast cancer","volume":"122","author":"Visser","year":"2008","journal-title":"Int J Cancer"},{"key":"key20180107212146_b36-or-34-05-2289","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.lungcan.2006.11.006","article-title":"CK19 mRnA expression measured by reverse-transcription polymerase chain reaction (RT-PCR) in the peripheral blood of patients with non-small cell lung cancer treated by chemoradiation: An independent prognostic factor","volume":"56","author":"Chen","year":"2007","journal-title":"Lung Cancer"},{"key":"key20180107212146_b37-or-34-05-2289","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1476-5926-9-4","article-title":"Keratin 19 marks poor differentiation and a more aggressive behaviour in canine and human hepatocellular tumours","volume":"9","author":"van Sprundel","year":"2010","journal-title":"Comp Hepatol"},{"key":"key20180107212146_b38-or-34-05-2289","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/BF02821609","article-title":"Cytokeratin 19 fragment in serum and tissues of patients with pancreatic diseases","volume":"21","author":"Ohshio","year":"1997","journal-title":"Int J Pancreatol"},{"key":"key20180107212146_b39-or-34-05-2289","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1002\/(SICI)1097-0215(20000401)86:1<89::AID-IJC14>3.0.CO;2-I","article-title":"Genetic immunization of mice with human tyrosinase-related protein 2: Implications for the immunotherapy of melanoma","volume":"86","author":"Steitz","year":"2000","journal-title":"Int J Cancer"},{"key":"key20180107212146_b40-or-34-05-2289","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1177\/107327480401100306","article-title":"Immunotherapeutic strategies for malignant glioma","volume":"11","author":"Fenstermaker","year":"2004","journal-title":"Cancer Control"}],"container-title":["Oncology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/or.2015.4231\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,13]],"date-time":"2023-08-13T12:50:19Z","timestamp":1691931019000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/or.2015.4231"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8,27]]},"references-count":40,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2015,8,27]]},"published-print":{"date-parts":[[2015,11]]}},"alternative-id":["10.3892\/or.2015.4231"],"URL":"https:\/\/doi.org\/10.3892\/or.2015.4231","relation":{},"ISSN":["1021-335X","1791-2431"],"issn-type":[{"value":"1021-335X","type":"print"},{"value":"1791-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,8,27]]}}}